MedTrace Logo

Effect of Bioactive Enriched Food on Markers of Metabolic Syndrome

NCT03956433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2019-05-20

No results posted yet for this study

Summary

This pilot study will investigate the enrichment type, in pancakes, most effective at improving markers of metabolic syndrome. Ready-made pancakes enriched with either docosahexaenoic acid (DHA), beta-glucan (BG) or anthocyanins (AC), alone or in combination of DHA+BG or DHA+AC, will be consumed for 4 weeks.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Ready-made pancakes enriched with docosahexaenoic acid (DHA)

One portion of DHA-enriched pancakes will be eaten each day for 4 weeks.

DIETARY_SUPPLEMENT

Ready-made pancakes enriched with beta-glucan (BG)

One portion of BG-enriched pancakes will be eaten each day for 4 weeks.

DIETARY_SUPPLEMENT

Ready-made pancakes enriched with anthocyanins (AC)

One portion of AC-enriched pancakes will be eaten each day for 4 weeks.

DIETARY_SUPPLEMENT

Ready-made pancakes enriched with docosahexaenoic acid and beta-glucan (DHA+BG)

One portion of DHA+BG-enriched pancakes will be eaten each day for 4 weeks.

DIETARY_SUPPLEMENT

Ready-made pancakes enriched with docosahexaenoic acid and anthocyanins (DHA+AC)

One portion of DHA+AC-enriched pancakes will be eaten each day for 4 weeks.

Sponsors & Collaborators

  • The Leeds Teaching Hospitals NHS Trust

    collaborator OTHER

  • AdWare Research Ltd.

    collaborator UNKNOWN

  • University of Bologna

    collaborator OTHER

  • European Union

    collaborator OTHER

  • University of Leeds

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2015-07-04
Completion
2015-07-04

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03956433 on ClinicalTrials.gov